Landesman, Yosef
Emory University · National and Kapodistrian University of Athens · NYU Langone Health · Karyopharm Therapeutics (United States) · Abramson Cancer Center · Tisch Cancer Institute · University of Pennsylvania · Icahn School of Medicine at Mount Sinai
3 papers on CoChatORCID 0000-0001-5542-5098
Most cited papers
- Verified
Oral selinexor-dexamethasone for triple-class refractory multiple myeloma.
Chari, A., Vogl, D. T., Gavriatopoulou, M., Nooka, A. K., Yee, A. J., Huff, C. A., Moreau, P., Dingli, D., Cole, C., Lonial, S., et al. (2019) · New England Journal of Medicine
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research
Cited by 666
- Verified
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer
Kim, J., McMillan, E., Kim, H. S., Venkateswaran, N., Makkar, G., Rodriguez-Canales, J., Villalobos, P., Neggers, J. E., Mendiratta, S., Wei, S., et al. (2016) · Nature
Nuclear Structure and FunctionLung Cancer Treatments and Mutations
Cited by 202
- Verified
Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer
Sexton, R., Mahdi, Z., Chaudhury, R., Beydoun, R., Aboukameel, A., Khan, H. Y., Baloglu, E., Senapedis, W., Landesman, Y., Tesfaye, A., et al. (2019) · International Journal of Molecular Sciences
Nuclear Structure and FunctionDrug Transport and Resistance Mechanisms
Cited by 47
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free